Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy: A Meta-analysis of Disease Progression Rates in Two Multicenter Clinical Trials

被引：0
|
作者：
Signorovitch, J.
Sajeev, G.
Yao, Z.
McDonnell, E.
Elfring, G.
Trifillis, P.
Souza, M.
Speltz, S.
Darras, B.
Shieh, P.
McDonald, C.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Neuromuscular Disorders; Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
189
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [41] Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
    Erik Landfeldt
    Rachel Thompson
    Thomas Sejersen
    Hugh J. McMillan
    Janbernd Kirschner
    Hanns Lochmüller
    European Journal of Epidemiology, 2020, 35 : 643 - 653
  • [42] Genetic Modifiers and Phenotype of Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis
    Pascual-Morena, Carlos
    Cavero-Redondo, Ivan
    Saz-Lara, Alicia
    Sequi-Dominguez, Irene
    Luceron-Lucas-Torres, Maribel
    Martinez-Vizcaino, Vicente
    PHARMACEUTICALS, 2021, 14 (08)
  • [43] Deflazacort Or Prednisone Treatment for Duchenne Muscular Dystrophy (DMD) Real-World Outcomes at Cincinnati Children's Hospital Medical Center (CCHMC)
    Marden, Jessica
    Santos, Claudio
    Trifillis, Panayiota
    Freimark, Jonathan
    Yao, Zhiwen
    Signorovitch, James
    Tian, Cuixia
    Wong, Brenda
    NEUROLOGY, 2020, 94 (15)
  • [44] Deflazacort or prednisone treatment for Duchenne muscular dystrophy (DMD): real-world outcomes at Cincinnati Children's Hospital Medical Center (CCHMC)
    Marden, J.
    Santos, C.
    Schilling, T.
    Friemark, J.
    Yao, Z.
    Signorovitch, J.
    Tian, C.
    Wong, B.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S174 - S174
  • [45] Clinical outcome of 22 years of daily deflazacort treatment in a 32-year-old patient with Duchenne muscular dystrophy
    Tian, C.
    Shellenbarger, K.
    Jefferies, J.
    Sawnani, H.
    McMahon, M.
    Watts, N.
    Wong, B.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S182 - S182
  • [46] Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status
    McDonald, Craig M.
    Marden, Jessica R.
    Shieh, Perry B.
    Wong, Brenda L.
    Lane, Henry
    Zhang, Adina
    Nguyen, Ha
    Frean, Molly
    Trifillis, Panayiota
    Koladicz, Karyn
    Signorovitch, James
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (04)
  • [47] Assessment of Treatment Effect With Multiple Outcomes in 2 Clinical Trials of Patients With Duchenne Muscular Dystrophy
    Li, Daniel
    McDonald, Craig M.
    Elfring, Gary L.
    Souza, Marcio
    McIntosh, Joseph
    Kim, Dae Hyun
    Wei, Lee-Jen
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [48] Life Expectancy in Duchenne Muscular Dystrophy Reproduced Individual Patient Data Meta-analysis
    Broomfield, Jonathan
    Hill, Micki
    Guglieri, Michela
    Crowther, Michael
    Abrams, Keith
    NEUROLOGY, 2021, 97 (23) : E2304 - E2314
  • [49] Comparison of surgical and non-surgical treatment for scoliosis in Duchenne muscular dystrophy: a systematic review and meta-analysis
    Liang, Haibo
    Shao, Zhenxuan
    Shi, Yifeng
    Wang, Xiangyang
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2025, 145 (01)
  • [50] Effectiveness of pharmacological treatments in Duchenne muscular dystrophy: a protocol for a systematic review and meta-analysis
    Pascual Morena, Carlos
    Martinez-Vizcaino, Vicente
    Alvarez-Bueno, Celia
    Fernandez Rodriguez, Ruben
    Jimenez Lopez, Estela
    Isabel Torres-Costoso, Ana
    Cavero-Redondo, Ivan
    BMJ OPEN, 2019, 9 (09):
12345